A U.K. study finds that identifying eating profiles through an online quiz can improve engagement and adherence in digital ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Medical weight loss is a personalized, medically ...

Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about willpower and food addiction.

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...

Weight loss drugs such as Ozempic, Mounjaro and Zepbound can deliver good results, but new research suggests the success may be short-lived. A new study suggests that that once people stop taking ...

User engagement in a digital weight-loss service enhanced the effectiveness of GLP-1 receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP)-GLP-1 receptor agonists in adults ...

Jerry Clark says he's transformed his tastebuds, changed his portion sizes, and made fitness a non-negotiable.

Midland Health’s Weigh to Success returns in 2026 with lifestyle medicine, CBT, medications and bariatric surgery to help ...